<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>The use of vocal biomarkers in the detection of Parkinson's disease: a robust statistical performance comparison of classic machine learning models - Health AI Hub</title>
    <meta name="description" content="This cross-sectional study demonstrates the superior performance of Deep Neural Networks (DNNs) over traditional Machine Learning (ML) models in detecting Parki">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>The use of vocal biomarkers in the detection of Parkinson's disease: a robust statistical performance comparison of classic machine learning models</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.16856v1" target="_blank">2511.16856v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-20
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Katia Pires Nascimento do Sacramento, Elliot Q. C. Garcia, Nic√©ias Silva Vilela, Vinicius P. Sacramento, Tiago A. E. Ferreira
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.16856v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.16856v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This cross-sectional study demonstrates the superior performance of Deep Neural Networks (DNNs) over traditional Machine Learning (ML) models in detecting Parkinson's disease (PD) using vocal biomarkers. Achieving high accuracies of up to 98.65%, the research highlights the potential of DNNs to provide an accurate, reliable, non-invasive, and cost-effective method for early diagnosis of neurodegenerative disorders.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Early and accurate diagnosis of Parkinson's disease is critical for timely intervention and disease management. This research offers a non-invasive, low-cost, and accessible diagnostic aid utilizing voice biomarkers, which could significantly improve early detection rates in clinical settings.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper describes the application of Deep Neural Networks and other machine learning models for the AI-assisted early detection and diagnosis of Parkinson's disease through the analysis of vocal biomarkers. This is a direct medical AI application aimed at improving diagnostic accuracy and accessibility in healthcare.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Parkinson's disease (PD) is associated with early vocal impairments like hypophonia and dysarthria, making vocal biomarkers a promising diagnostic tool.</li>
                    
                    <li>The study compared the effectiveness of a Deep Neural Network (DNN) against traditional Machine Learning (ML) models for PD detection using voice data.</li>
                    
                    <li>Two publicly available voice datasets were utilized, and Mel-frequency cepstral coefficients (MFCCs) were extracted as vocal biomarkers.</li>
                    
                    <li>Model robustness was rigorously assessed using a validation strategy involving 1000 independent random executions, with performance evaluated by classification statistics.</li>
                    
                    <li>Non-parametric statistical tests (Kruskal-Wallis and Bonferroni post-hoc) were employed due to the non-satisfaction of normality assumptions, ensuring robust comparison.</li>
                    
                    <li>The DNN achieved average accuracies of 98.65% on the Italian Voice dataset and 92.11% on the Parkinson's Telemonitoring dataset, outperforming traditional ML models.</li>
                    
                    <li>The findings confirm the efficiency of DNNs and their potential for enhanced accuracy and reliability in the early detection of neurodegenerative diseases via voice-based analysis.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>This was a cross-sectional comparative study evaluating a Deep Neural Network against traditional Machine Learning models for PD detection. Two publicly available voice datasets were used, from which Mel-frequency cepstral coefficients (MFCCs) were extracted as features. Model robustness was assessed through 1000 independent random executions, and performance was evaluated using classification statistics. Non-parametric tests (Kruskal-Wallis and Bonferroni post-hoc) were applied for statistical comparison of model performances.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The Deep Neural Network demonstrated superior performance, achieving average classification accuracies of 98.65% on the Italian Voice dataset and 92.11% on the Parkinson's Telemonitoring dataset. It consistently outperformed traditional Machine Learning models and showed competitive results against benchmarks from existing literature in distinguishing individuals with Parkinson's disease from healthy controls.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research provides a strong foundation for developing highly accurate, non-invasive, and accessible tools for the early screening and diagnosis of Parkinson's disease. The high accuracy of DNNs using vocal biomarkers could facilitate earlier clinical intervention, potentially leading to improved patient outcomes and more efficient resource allocation in healthcare systems.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state limitations of the study. Common potential limitations for this type of research, which are not discussed in the abstract, could include the generalizability of findings to diverse populations, the specific set of 'traditional ML methods' used for comparison, and the lack of longitudinal validation.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly stated as future research directions, the study emphasizes the potential of DNNs for providing greater accuracy and reliability in the early detection of neurodegenerative diseases. This implicitly suggests future work towards clinical validation, integration into real-world diagnostic workflows, and potentially exploration of multimodal biomarker approaches.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Neurodegeneration</span>
                    
                    <span class="tag">Speech-Language Pathology</span>
                    
                    <span class="tag">Diagnostic Medicine</span>
                    
                    <span class="tag">Telemedicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Parkinson's Disease</span>
                    
                    <span class="tag tag-keyword">Vocal Biomarkers</span>
                    
                    <span class="tag tag-keyword">Deep Neural Network</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                    <span class="tag tag-keyword">Early Detection</span>
                    
                    <span class="tag tag-keyword">Hypophonia</span>
                    
                    <span class="tag tag-keyword">Dysarthria</span>
                    
                    <span class="tag tag-keyword">MFCCs</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Parkinson's disease (PD) is a progressive neurodegenerative disorder that, in addition to directly impairing functional mobility, is frequently associated with vocal impairments such as hypophonia and dysarthria, which typically manifest in the early stages. The use of vocal biomarkers to support the early diagnosis of PD presents a non-invasive, low-cost, and accessible alternative in clinical settings. Thus, the objective of this cross-sectional study was to consistently evaluate the effectiveness of a Deep Neural Network (DNN) in distinguishing individuals with Parkinson's disease from healthy controls, in comparison with traditional Machine Learning (ML) methods, using vocal biomarkers. Two publicly available voice datasets were used. Mel-frequency cepstral coefficients (MFCCs) were extracted from the samples, and model robustness was assessed using a validation strategy with 1000 independent random executions. Performance was evaluated using classification statistics. Since normality assumptions were not satisfied, non-parametric tests (Kruskal-Wallis and Bonferroni post-hoc tests) were applied to verify whether the tested classification models were similar or different in the classification of PD. With an average accuracy of $98.65\%$ and $92.11\%$ on the Italian Voice dataset and Parkinson's Telemonitoring dataset, respectively, the DNN demonstrated superior performance and efficiency compared to traditional ML models, while also achieving competitive results when benchmarked against relevant studies. Overall, this study confirms the efficiency of DNNs and emphasizes their potential to provide greater accuracy and reliability for the early detection of neurodegenerative diseases using voice-based biomarkers.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>18 pages, 3 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>